Medium impact
Ablation of Hepatic Lesions (CPB 0274, reviewed 2026-06-08)
Aetna·Effective Jun 8, 2026
HCPCS C9790 is officially defined as "Histotripsy (i.e., non-thermal ablation via acoustic energy delivery) of malignant renal tissue, including image guidance." HCPCS C9790 is referenced in 1 tracked payer policy change from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS C9790 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.